Literature DB >> 6863264

The presence of intermolecular disulfide cross-links in type III collagen.

D T Cheung, P DiCesare, P D Benya, E Libaw, M E Nimni.   

Abstract

Bovine and lathyritic rat type III collagen preparations were analyzed for the presence and in vitro formation of intermolecular disulfide cross-links. Type III collagen from fetal bovine skin was extracted with the aid of pepsin and purified by differential salt precipitation, guanidine denaturation, and renaturation. Nearly all of the type III collagen was present as reduction-sensitive gamma-components and higher molecular weight aggregates. After cleavage with CNBr, the peptides were analyzed by two-dimensional mapping. The presence of intermolecular disulfide bonds was demonstrated by the existence of a hexamer of the COOH-terminal CNBr peptide, CB9B. This cross-linked peptide was completely converted to the CB9B monomer by reduction. Type III collagen from the skins of beta-aminoproprionitrile-treated rats was used to test for the in vitro formation of intermolecular disulfide cross-links. This was prepared by salt extraction, differential salt precipitation, and pepsin treatment. Sodium dodecyl sulfate-gel electrophoresis of this partially purified type III collagen before reconstitution into fibers detected primarily gamma-chains. After reconstitution into fibers, the majority of the material was present as higher molecular weight aggregates. Upon reduction, these aggregates generated predominantly alpha-chains. These data demonstrate the existence of intermolecular disulfide bonds in native type III collagen and their formation during in vitro fibrillogenesis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6863264

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  A novel fibre-ensemble level constitutive model for exogenous cross-linked collagenous tissues.

Authors:  Michael S Sacks; Will Zhang; Silvia Wognum
Journal:  Interface Focus       Date:  2016-02-06       Impact factor: 3.906

2.  The effect of corticosteroid on collagen expression in injured rotator cuff tendon.

Authors:  Anthony S Wei; John J Callaci; Dainius Juknelis; Guido Marra; Pietro Tonino; Kevin B Freedman; Frederick H Wezeman
Journal:  J Bone Joint Surg Am       Date:  2006-06       Impact factor: 5.284

3.  Cross-link analysis of the C-telopeptide domain from type III collagen.

Authors:  W Henkel
Journal:  Biochem J       Date:  1996-09-01       Impact factor: 3.857

4.  Collagen gene construction and evolution.

Authors:  B Runnegar
Journal:  J Mol Evol       Date:  1985       Impact factor: 2.395

5.  Collagen defects in lethal perinatal osteogenesis imperfecta.

Authors:  J F Bateman; D Chan; T Mascara; J G Rogers; W G Cole
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

6.  Modeling the response of exogenously crosslinked tissue to cyclic loading: The effects of permanent set.

Authors:  Will Zhang; Michael S Sacks
Journal:  J Mech Behav Biomed Mater       Date:  2017-07-11

Review 7.  Soft Materials by Design: Unconventional Polymer Networks Give Extreme Properties.

Authors:  Xuanhe Zhao; Xiaoyu Chen; Hyunwoo Yuk; Shaoting Lin; Xinyue Liu; German Parada
Journal:  Chem Rev       Date:  2021-04-12       Impact factor: 72.087

8.  Changes of Material Elastic Properties during Healing of Ruptured Achilles Tendons Measured with Shear Wave Elastography: A Pilot Study.

Authors:  Borys Frankewycz; Leopold Henssler; Johannes Weber; Natascha Platz Batista da Silva; Matthias Koch; Ernst Michael Jung; Denitsa Docheva; Volker Alt; Christian G Pfeifer
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

9.  Strain Elastography of Injured Equine Superficial Digital Flexor Tendons: A Reliability Study of Manual Measurements.

Authors:  Valentina Secchi; Gerolamo Masala; Andrea Corda; Francesca Corda; Enrica Potop; Alicia Barbero Fernandez; Maria Luisa Pinna Parpaglia; Eraldo Sanna Passino
Journal:  Animals (Basel)       Date:  2021-03-12       Impact factor: 2.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.